$58.08
2.69% yesterday
Nasdaq, May 28, 10:14 pm CET
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Exact Sciences Corporation Stock price

$58.08
+12.49 27.40% 1M
-3.61 5.85% 6M
+1.89 3.36% YTD
+11.06 23.52% 1Y
+4.25 7.90% 3Y
-25.81 30.77% 5Y
+30.95 114.08% 10Y
Nasdaq, Closing price Wed, May 28 2025
+1.52 2.69%
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Key metrics

Market capitalization $10.96b
Enterprise Value $12.51b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 83.88
EV/Sales (TTM) EV/Sales 4.42
P/S ratio (TTM) P/S ratio 3.87
P/B ratio (TTM) P/B ratio 4.57
Revenue growth (TTM) Revenue growth 11.57%
Revenue (TTM) Revenue $2.83b
EBIT (operating result TTM) EBIT $-166.76m
Free Cash Flow (TTM) Free Cash Flow $149.14m
Cash position $786.18m
EPS (TTM) EPS $-5.45
P/E forward negative
P/S forward 3.53
EV/Sales forward 4.04
Short interest 6.13%
Show more

Is Exact Sciences Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Exact Sciences Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Exact Sciences Corporation forecast:

27x Buy
90%
3x Hold
10%

Analyst Opinions

30 Analysts have issued a Exact Sciences Corporation forecast:

Buy
90%
Hold
10%

Financial data from Exact Sciences Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,828 2,828
12% 12%
100%
- Direct Costs 876 876
31% 31%
31%
1,952 1,952
5% 5%
69%
- Selling and Administrative Expenses 1,654 1,654
0% 0%
58%
- Research and Development Expense 426 426
3% 3%
15%
48 48
133% 133%
2%
- Depreciation and Amortization 215 215
132% 132%
8%
EBIT (Operating Income) EBIT -167 -167
30% 30%
-6%
Net Profit -1,020 -1,020
325% 325%
-36%

In millions USD.

Don't miss a Thing! We will send you all news about Exact Sciences Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Exact Sciences Corporation Stock News

Neutral
Business Wire
about 23 hours ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced new data to be presented from the Beta-CORRECT clinical validation study at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. Results from Beta-CORRECT, a subset of the GALAXY cohort, validate the performance of its tumor-informed ...
Neutral
Business Wire
one day ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast. William Blair 45th Annual Growth Stock Conference, Chicago Presentation on Tuesday, June 3, 2025 at 9:40 a.m. ET The webcast can be a...
Neutral
Business Wire
6 days ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it will present ten abstracts at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30–June 3, 2025, in Chicago, Ill. Presentations include new data on the Oncodetect™ molecular residual disease (MRD) test, multi-ca...
More Exact Sciences Corporation News

Company Profile

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Head office United States
CEO Kevin Conroy
Employees 6,950
Founded 1995
Website www.exactsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today